{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T04:13:50Z","timestamp":1684815230043},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02639-9","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:02:56Z","timestamp":1674043376000},"page":"2101-2107","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visual evoked potential changes following Botox administration in patients with blepharospasm"],"prefix":"10.1007","volume":"43","author":[{"given":"Mehmet Tahir","family":"Eski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuddusi","family":"Teberik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz Hudai","family":"Ayasli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"2639_CR1","first-page":"220","volume":"51","author":"ER Barbosa","year":"1996","unstructured":"Barbosa ER, Silva HC, Haddad MS et al (1996) Blepharospasm: treatment with botulinum toxin. Rev Hosp Clin Fac Med Sao Paulo 51:220\u2013223","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"2639_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-2007-971171","volume":"27","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Singer C (2007) Botulinum toxin in movement disorders. Semin Neurol 27:183\u2013194","journal-title":"Semin Neurol"},{"key":"2639_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3341\/kjo.2018.0038","volume":"32","author":"JM Lee","year":"2018","unstructured":"Lee JM, Baek JS, Choi HS et al (2018) Clinical features of benign essential blepharospasm in Korean patients. Korean J Ophthalmol 32:339\u2013343","journal-title":"Korean J Ophthalmol"},{"key":"2639_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.21084","volume":"21","author":"G Cossu","year":"2006","unstructured":"Cossu G, Mereu A, Deriu M et al (2006) Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey. Mov Disord 21:2005\u20132008","journal-title":"Mov Disord"},{"key":"2639_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.870030302","volume":"3","author":"JG Nutt","year":"1988","unstructured":"Nutt JG, Muenter MD, Aronson A et al (1988) Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 3:188\u2013194","journal-title":"Mov Disord"},{"key":"2639_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N et al (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51:767\u2013772","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2639_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41433-019-0495-y","volume":"33","author":"A Fantato","year":"2019","unstructured":"Fantato A, Parulekar M, Elston J (2019) A trial of a mechanical device for the treatment of blepharospasm. Eye (Lond) 33:1803\u20131808","journal-title":"Eye (Lond)"},{"issue":"Suppl 2","key":"2639_CR8","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1002\/mds.10063","volume":"17","author":"A Berardelli","year":"2002","unstructured":"Berardelli A, Curra A (2002) Pathophysiology and treatment of cranial dystonia. Mov Disord 17(Suppl 2):S70-74","journal-title":"Mov Disord"},{"key":"2639_CR9","first-page":"775","volume":"63","author":"Y Mukai","year":"2011","unstructured":"Mukai Y, Kaji R (2011) Use of botulinum neurotoxin therapy. Brain Nerve 63:775\u2013784","journal-title":"Brain Nerve"},{"key":"2639_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/11584780-000000000-00000","volume":"10","author":"J Frevert","year":"2010","unstructured":"Frevert J (2010) Content of botulinum neurotoxin in Botox\u00ae\/Vistabel\u00ae, Dysport\u00ae\/Azzalure\u00ae, and Xeomin\u00ae\/Bocouture\u00ae. Drugs R D 10:67\u201373","journal-title":"Drugs R D"},{"key":"2639_CR11","first-page":"169","volume":"78","author":"J Jankovic","year":"1998","unstructured":"Jankovic J (1998) Medical therapy and botulinum toxin in dystonia. Adv Neurol 78:169\u2013183","journal-title":"Adv Neurol"},{"key":"2639_CR12","doi-asserted-by":"publisher","first-page":"E269","DOI":"10.3390\/toxins12040269","volume":"12","author":"TJW Hassell","year":"2020","unstructured":"Hassell TJW, Charles D (2020) Treatment of blepharospasm and oromandibular dystonia with botulinum toxins. Toxins (Basel) 12:E269","journal-title":"Toxins (Basel)"},{"key":"2639_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/164_2019_339","volume":"263","author":"A Berardelli","year":"2021","unstructured":"Berardelli A, Conte A (2021) The use of botulinum toxin for treatment of the dystonias. Handb Exp Pharmacol 263:107\u2013126","journal-title":"Handb Exp Pharmacol"},{"key":"2639_CR14","volume-title":"Ocular electrophysiology","author":"N Tamcelik","year":"2011","unstructured":"Tamcelik N (2011) Ocular electrophysiology, 2011th edn. Turkish Ophthalmological Association Education Publications, Istanbul","edition":"2011"},{"key":"2639_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.22368","volume":"24","author":"J Jankovic","year":"2009","unstructured":"Jankovic J, Kenney C, Grafe S et al (2009) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24:407\u2013413","journal-title":"Mov Disord"},{"key":"2639_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1080\/02713683.2018.1464191","volume":"43","author":"K Namiguchi","year":"2018","unstructured":"Namiguchi K, Mizoue S, Ohta K et al (2018) Effect of botulinum Toxin A treatment on eyelid pressure in eyes with blepharospasm. Curr Eye Res 43:896\u2013901","journal-title":"Curr Eye Res"},{"key":"2639_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1001724411607","volume":"95","author":"M Brigell","year":"1998","unstructured":"Brigell M, Bach M, Barber C et al (1998) Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Calibration Standard Committee of the International Society for Clinical Electrophysiology of Vision (ISCEV). Doc Ophthalmol 95:1\u201314","journal-title":"Doc Ophthalmol"},{"key":"2639_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ncl.2014.09.002","volume":"33","author":"HA Jinnah","year":"2015","unstructured":"Jinnah HA, Factor SA (2015) Diagnosis and treatment of dystonia. Neurol Clin 33:77\u2013100","journal-title":"Neurol Clin"},{"key":"2639_CR19","unstructured":"Patel B, Weinstein G (1998) Diagnosis and treatment of blepharspazm. Mosby Press, Louis St. In Nesi FA, Lisman RD, Levien MR"},{"key":"2639_CR20","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1001\/jama.1982.03320480060028","volume":"247","author":"JM Powers","year":"1982","unstructured":"Powers JM (1982) Decongestant-induced blepharospasm and orofacial dystonia. JAMA 247:3244\u20133245","journal-title":"JAMA"},{"key":"2639_CR21","first-page":"371","volume":"16","author":"J Jankovic","year":"1984","unstructured":"Jankovic J, Orman J (1984) Blepharospasm: demographic and clinical survey of 250 patients. Ann Ophthalmol 16:371\u2013376","journal-title":"Ann Ophthalmol"},{"key":"2639_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/mdc3.12291","volume":"2","author":"C Colosimo","year":"2015","unstructured":"Colosimo C, Bologna M, Berardelli A (2015) How Do I Examine Blepharospasm? Mov Disord Clin Pract 2:449","journal-title":"Mov Disord Clin Pract"},{"key":"2639_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/S0004-27492010000500018","volume":"73","author":"AGB Nicoletti","year":"2010","unstructured":"Nicoletti AGB, Aoki L, Nahas TR et al (2010) Essential blepharospasm: literature review. Arq Bras Oftalmol 73:469\u2013473","journal-title":"Arq Bras Oftalmol"},{"key":"2639_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/B:DOOP.0000036790.67234.22","volume":"108","author":"JV Odom","year":"2004","unstructured":"Odom JV, Bach M, Barber C et al (2004) Visual evoked potentials standard (2004). Doc Ophthalmol 108:115\u2013123","journal-title":"Doc Ophthalmol"},{"key":"2639_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s100670200083","volume":"21","author":"J Finsterer","year":"2002","unstructured":"Finsterer J, St\u00f6llberger C, Shinar Y (2002) Cranial nerve lesions and abnormal visually evoked potentials associated with the M694V mutation in familial Mediterranean fever. Clin Rheumatol 21:317\u2013321","journal-title":"Clin Rheumatol"},{"key":"2639_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","volume":"133","author":"JV Odom","year":"2016","unstructured":"Odom JV, Bach M, Brigell M et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133:1\u20139","journal-title":"Doc Ophthalmol"},{"key":"2639_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17116\/oftalma2018134319","volume":"134","author":"NI Kurysheva","year":"2018","unstructured":"Kurysheva NI, Maslova EV, Trubilina AV et al (2018) Pattern visual evoked potentials and their relation to the peripapillary and retrobulbar blood flow in glaucoma. Vestn Oftalmol 134:19\u201327","journal-title":"Vestn Oftalmol"},{"key":"2639_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10633-019-09731-5","volume":"140","author":"R Amini Vishteh","year":"2020","unstructured":"Amini Vishteh R, Mirzajani A, Jafarzadehpur E et al (2020) Evaluation of visual evoked potential binocular summation after corneal refractive surgery. Doc Ophthalmol 140:181\u2013188","journal-title":"Doc Ophthalmol"},{"key":"2639_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0886-3350(00)00447-8","volume":"26","author":"J Lavinsky","year":"2000","unstructured":"Lavinsky J, Gus PI, Ehlers JA et al (2000) Visual-evoked potentials: assessment of retrobulbar and peribulbar anesthesia. J Cataract Refract Surg 26:1529\u20131532","journal-title":"J Cataract Refract Surg"},{"key":"2639_CR30","first-page":"414","volume":"8","author":"ML Alimgil","year":"2001","unstructured":"Alimgil ML, Benian \u00d6, Esgin H (2001) Tiroid Orbitopatide Ok\u00fcler Nab\u0131z Genli\u011fi. G\u00f6rme Alan\u0131 ve Vep MNO 8:414\u2013416","journal-title":"G\u00f6rme Alan\u0131 ve Vep MNO"},{"key":"2639_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jcms.2012.01.027","volume":"40","author":"LC Clauser","year":"2012","unstructured":"Clauser LC, Tieghi R, Galie\u2019 M et al (2012) Surgical decompression in endocrine orbitopathy. Visual evoked potential evaluation and effect on the optic nerve. J Craniomaxillofac Surg 40:621\u2013625","journal-title":"J Craniomaxillofac Surg"},{"key":"2639_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1055\/s-0035-1563580","volume":"35","author":"RA Egan","year":"2015","unstructured":"Egan RA, LaFrance WC (2015) Functional vision disorder. Semin Neurol 35:557\u2013563","journal-title":"Semin Neurol"},{"key":"2639_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101995","volume":"24","author":"Y Suzuki","year":"2019","unstructured":"Suzuki Y, Kiyosawa M, Wakakura M et al (2019) Glucose hypometabolism in the visual cortex proportional to disease severity in patients with essential blepharospasm. Neuroimage Clin 24:101995","journal-title":"Neuroimage Clin"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02639-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T07:22:31Z","timestamp":1684740151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["2639"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02639-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"14 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee (Duzce University Faculty of Medicine) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}